Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Phase
Not applicable
Started
2025-05-01
Last updated
2026-01-21
Condition(s) studied
Sedentary BehaviorHealthy ParticipantsAdult
Investigational drug(s) / intervention(s)
Exercise intervention
Exercise intervention: Exercise prescription for participant,
* 150Kcal for Weeks 1-4 (gradually increase to 150Kcal in the first two weeks as familiar stage),
* 250Kcal for Weeks 5-8,
* 350Kcal for Weeks 9-12.
Study summary
The goal of this clinical trial is to study the effectiveness of aerobic exercise in treating obesity in adults and to assess the efficacy of exercise. The primary research questions it seeks to address are as follows:
* To what extent does exercise increase the total energy expenditure of participants?
* Why and how does the energy expenditure from exercise not fully compensate for the total energy expenditure (TEE)?
* Researchers will assess the efficacy and potential challenges of using exercise as a treatment for obesity by comparing the measurement data before exercise intervention (week 0), immediately after exercise intervention (week 12), and 8 weeks post-completion of exercise intervention (week 20).
Participants will engage in the following activities:
* Engage in running sessions supervised five times a week for a duration of 12 weeks.
* Attend laboratory sessions both before and after the exercise intervention period for metabolic and anthropometric measurements, as well as sample collection.
* Return to the laboratory for further metabolic and anthropometric measurements and sample collection8 weeks post-completion of exercise intervention.
Eligibility
Sex
ALL
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Sedentary individuals
* BMI ≥ 18.5 kg/m2
Exclusion Criteria:
* Individuals who have undergone major surgery in the past 6 months (excluding tooth extraction);
* Individuals on long-term medication;
* Individuals with metabolic and cardiovascular diseases such as diabetes, hypoglycemia, and hypertension;
* Individuals with exercise-related injuries, including joint diseases and fractures;
* Individuals diagnosed with infectious diseases such as HIV, tuberculosis, malaria, etc.;
* Individuals with mental and neurological disorders including anorexia nervosa;
* Individuals who have attempted weight loss or gain through various methods in the past three months;
* Individuals in preconception, pregnancy, and lactation periods;
* Individuals with autism and those with metal implants in their bodies.
Primary outcome measure(s)
Change in TEE. — Three times, it takes 14 days for each time: before exercise intervention (week 0), immediately after exercise intervention (week 12), and 8 weeks post-completion of exercise intervention (week 20). The change in TEE will be evaluated using the DLW method before and after exercise intervention.
Change in TEF and REE. — Three times, it takes 1 days for each time: before exercise intervention (week 0), immediately after exercise intervention (week 12), and 8 weeks post-completion of exercise intervention (week 20). The change in BEE and TEF will be measured through indirect calorimetry in a respiratory chamber.
Change in exercise energy expenditure. — Three times, it takes 14 days for each time: before exercise intervention (week 0), immediately after exercise intervention (week 12), and 8 weeks post-completion of exercise intervention (week 20). The change in exercise energy expenditure will be assessed using indirect calorimetry with a respiratory hood system (COSMED).
Change in food intake. — Three times, food intake assessment takes 2 days: before exercise intervention (week 0), immediately after exercise intervention (week 12), and 8 weeks post-completion of exercise intervention (week 20). Food intake will be assessed using a 2-day food record complemented by photographing and weighing the food before and after consumption.
Change in physical activity. — Three times, it takes takes 14 days: before exercise intervention (week 0), immediately after exercise intervention (week 12), and 8 weeks post-completion of exercise intervention (week 20). The physical activity levels of the participants will be monitored through the use of a GT3X accelerometer.
Trial sites (1)
Facility
City
Region
Status
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Shenzhen
Guangdong
Recruiting
More Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.